Skip To Main Content
Arran D. Dokal on Muck Rack

Arran D. Dokal

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Arran D. Dokal’s profile

Articles by Arran D. Dokal

Computational Analysis of Cholangiocarcinoma Phosphoproteomes Identifies Patient-Specific Drug Targets

|
By Shirin Elizabeth Khorsandi, Arran D. Dokal, Vinothini Rajeeve
| cancerres.aacrjournals.org
Convergence and Technologies Shirin Elizabeth Khorsandi, Arran D. Dokal, Vinothini Rajeeve, David J. Britton, Megan S. Illingworth, Nigel Heaton and Pedro R. Cutillas DOI: 10.1158/0008-5472.CAN-21-0955 Published November 2021 Abstract Cholangiocarcinoma is a form of hepatobiliary cancer with an abysmal prognosis. Despite advances in our understanding of cholangiocarcinoma pathophysiology and its genomic landscape, targeted therapies have not yet made a significant impact on its clinical management.
Open in Who Shared Issue with article?

Computational analysis of cholangiocarcinoma phosphoproteomes identifies patient-specific drug targets

|
By Shirin Elizabeth Khorsandi, Arran D. Dokal, Vinothini Rajeeve, David Britton
| cancerres.aacrjournals.org
Research Article Shirin Elizabeth Khorsandi, Arran D. Dokal, Vinothini Rajeeve, David J Britton, Megan Illingworth, Nigel Heaton and Pedro R. Cutillas DOI: 10.1158/0008-5472.CAN-21-0955 Abstract Cholangiocarcinoma (CCA) is a form of hepatobiliary cancer with an abysmal prognosis. Despite advances in our understanding of CCA pathophysiology and its genomic landscape, targeted therapies have not yet made a significant impact on its clinical management.
Open in Who Shared Issue with article?
Show More